These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin. Gohlke P; Kuwer I; Bartenbach S; Schnell A; Unger T J Cardiovasc Pharmacol; 1994 Sep; 24(3):462-9. PubMed ID: 7528303 [TBL] [Abstract][Full Text] [Related]
3. Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin. Gohlke P; Unger T Am J Cardiol; 1995 Nov; 76(15):41E-45E. PubMed ID: 7484888 [TBL] [Abstract][Full Text] [Related]
4. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145 [TBL] [Abstract][Full Text] [Related]
5. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction. Linz W; Gohlke P; Unger T; Schölkens BA Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309 [TBL] [Abstract][Full Text] [Related]
6. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist. Schölkens BA; Linz W; König W J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732 [TBL] [Abstract][Full Text] [Related]
7. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Gohlke P; Linz W; Schölkens BA; Wiemer G; Unger T Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823 [TBL] [Abstract][Full Text] [Related]
8. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy. Linz W; Wiemer G; Schölkens BA Braz J Med Biol Res; 1994 Aug; 27(8):1949-54. PubMed ID: 7749386 [TBL] [Abstract][Full Text] [Related]
9. Local inhibition of bradykinin degradation in ischemic hearts. Linz W; Martorana PA; Schölkens BA J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370 [TBL] [Abstract][Full Text] [Related]
10. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study. Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995 [TBL] [Abstract][Full Text] [Related]
11. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. Bao G; Gohlke P; Unger T J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637 [TBL] [Abstract][Full Text] [Related]
12. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525 [TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy. Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963 [TBL] [Abstract][Full Text] [Related]
14. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560 [TBL] [Abstract][Full Text] [Related]
16. Contribution of bradykinin to the cardiovascular effects of ramipril. Linz W; Wiemer G; Schölkens BA J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S1-8. PubMed ID: 7514234 [TBL] [Abstract][Full Text] [Related]